Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A. Sujenthiran is active.

Publication


Featured researches published by A. Sujenthiran.


British Journal of Cancer | 2018

Robot-assisted radical prostatectomy vs laparoscopic and open retropubic radical prostatectomy: functional outcomes 18 months after diagnosis from a national cohort study in England

J. Nossiter; A. Sujenthiran; Susan Charman; Paul Cathcart; Ajay Aggarwal; Heather Payne; Noel W. Clarke; Jan van der Meulen

Background:Robot-assisted radical prostatectomy (RARP) has been rapidly adopted without robust evidence comparing its functional outcomes against laparoscopic radical prostatectomy (LRP) or open retropubic radical prostatectomy (ORP) approaches. This study compared patient-reported functional outcomes following RARP, LRP or ORP.Methods:All men diagnosed with prostate cancer in England during April – October 2014 who underwent radical prostatectomy were identified from the National Prostate Cancer Audit and mailed a questionnaire 18 months after diagnosis. Group differences in patient-reported sexual, urinary, bowel and hormonal function (EPIC-26 domain scores) and generic health-related quality of life (HRQoL; EQ-5D-5L scores), with adjustment for patient and tumour characteristics, were estimated using linear regression.Results:In all, 2219 men (77.0%) responded; 1310 (59.0%) had RARP, 487 (21.9%) LRP and 422 (19.0%) ORP. RARP was associated with slightly higher adjusted mean EPIC-26 sexual function scores compared with LRP (3·5 point difference; 95% CI: 1.1–5.9, P=0.004) or ORP (4.0 point difference; 95% CI: 1.5–6.5, P=0.002), which did not meet the threshold for a minimal clinically important difference (10–12 points). There were no significant differences in other EPIC-26 domain scores or HRQoL.Conclusions:It is unlikely that the rapid adoption of RARP in the English NHS has produced substantial improvements in functional outcomes for patients.


BJUI | 2017

Quantifying severe urinary complications after radical prostatectomy: the development and validation of a surgical performance indicator using hospital administrative data

A. Sujenthiran; Susan Charman; Matthew Parry; J. Nossiter; Ajay Aggarwal; Prokar Dasgupta; Heather Payne; Noel W. Clarke; Paul Cathcart; Jan van der Meulen

To develop and validate a surgical performance indicator based on severe urinary complications that require an intervention within 2 years of radical prostatectomy (RP), identified in hospital administrative data.


BJUI | 2018

National cohort study comparing severe medium-term urinary complications after robot-assisted vs laparoscopic vs retropubic open radical prostatectomy

A. Sujenthiran; J. Nossiter; Matthew Parry; Susan Charman; Ajay Aggarwal; Heather Payne; Prokar Dasgupta; Noel W. Clarke; J van der Meulen; Paul Cathcart

To evaluate the occurrence of severe urinary complications within 2 years of surgery in men undergoing either robot‐assisted radical prostatectomy (RARP), laparoscopic radical prostatectomy (LRP) or retropubic open radical prostatectomy (ORP).


Radiotherapy and Oncology | 2018

Treatment-related toxicity in men who received Intensity-modulated versus 3D-conformal radiotherapy after radical prostatectomy: A national population-based study

A. Sujenthiran; J. Nossiter; Matthew Parry; Susan Charman; Paul Cathcart; Jan van der Meulen; Noel W. Clarke; Heather Payne; Ajay Aggarwal

BACKGROUND AND PURPOSE In the post-prostatectomy setting the value of Intensity-modulated (IMRT) relative to 3D-conformal radiotherapy (3D-CRT) in reducing toxicity remains unclear. We compared genitourinary (GU) and gastrointestinal (GI) toxicity after post-prostatectomy IMRT or 3D-CRT. MATERIALS AND METHODS A population-based study of all patients treated with post-prostatectomy 3D-CRT (n = 2422) and IMRT (n = 603) was conducted between January 1 2010 and December 31 2013 in the English National Health Service. We identified severe GI and GU toxicity using a validated coding-framework and compared IMRT and 3D-CRT using a competing-risks proportional hazards regression analysis. RESULTS There was no difference in GI toxicity between patients who received IMRT and 3D-CRT (3D-CRT: 5.8 events/100 person-years; IMRT: 5.5 events/100 person-years; adjusted HR: 0.85, 95%CI: 0.63-1.13; p = 0.26). The GU toxicity rate was lower with IMRT but this effect was not statistically significant (3D-CRT: 5.4 events/100 person-years; IMRT: 3.8 events/100 person-years; adjusted HR: 0.76, 95%CI: 0.55-1.03; p = 0.08). CONCLUSIONS The use of post-prostatectomy IMRT compared to 3D-CRT is not associated with a statistically significant reduction in rates of severe GU and GI toxicity, although there is some evidence that GU toxicity is lower with IMRT. We would caution against rapid transition to post-prostatectomy IMRT until further evidence is available supporting its superiority.


International Journal of Radiation Oncology Biology Physics | 2017

National Population-Based Study Comparing Treatment-Related Toxicity in Men Who Received Intensity Modulated Versus 3-Dimensional Conformal Radical Radiation Therapy for Prostate Cancer

A. Sujenthiran; J. Nossiter; Susan Charman; Matthew Parry; Prokar Dasgupta; J van der Meulen; Paul Cathcart; Noel W. Clarke; H. Payne; Ajay Aggarwal


International Journal of Radiation Oncology Biology Physics | 2017

Hospital Quality Factors Influencing the Mobility of Patients for Radical Prostate Cancer Radiation Therapy: A National Population-Based Study

Ajay Aggarwal; Daniel Lewis; A. Sujenthiran; Susan Charman; Richard Sullivan; Heather Payne; Malcolm David Mason; Jan van der Meulen


International Journal of Radiation Oncology Biology Physics | 2017

Determinants of Patient Mobility for Radical Prostate Cancer Radiation Therapy in the Precision Medicine Era: A Population-Based Study of Choice and Competition in England

Ajay Aggarwal; Daniel Lewis; A. Sujenthiran; Susan Charman; Richard Sullivan; Malcolm David Mason; J van der Meulen


European Urology Supplements | 2014

123 Long-term outcome following management of muscle invasive bladder cancer: Bladder-sparing Radical Therapy (BRT) and subsequent salvage cystectomy versus immediate primary cystectomy

A. Sujenthiran; J van der Meulen; John D. Kelly; P. Cathcart


European Urology Supplements | 2017

Current national trends in the management of locally advanced prostate cancer with radical therapies: Results from the English National Prostate Cancer Audit

A. Sujenthiran; J. Nossiter; Susan Charman; Ajay Aggarwal; P. Cathcart; Heather Payne; Noel W. Clarke; J van der Meulen


European Urology Supplements | 2017

Impact of type of radical prostatectomy on outcomes reported by men with prostate cancer 18 months post-diagnosis: Results from the English National Prostate Cancer Audit (NPCA)

J. Nossiter; A. Sujenthiran; Susan Charman; P. Cathcart; Ajay Aggarwal; Heather Payne; Noel W. Clarke; J van der Meulen

Collaboration


Dive into the A. Sujenthiran's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. Nossiter

Royal College of Surgeons of England

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paul Cathcart

Guy's and St Thomas' NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar

Heather Payne

University College Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

P. Cathcart

St Bartholomew's Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge